Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Jorgenson

Showing results (31-40 of 72) with videos related to

Pageof 8
Sort By:
The Annals of Pharmacotherapy|May 18, 2017
Fosfomycin tromethamine for the Treatment of Cystitis in Abdominal Solid Organ Transplant Recipients With Renal DysfunctionLuiza Kerstenetzky, Margaret R Jorgenson, Jillian L Descourouez, et al.
Transplantation Direct|May 31, 2021
Geographic Distribution of Cytomegalovirus Serology in Kidney and Pancreas Transplant Recipients in the United StatesMargaret R Jorgenson, Sandesh Parajuli, Nicholas Marka, et al.
Clinical Transplantation|June 14, 2019
The risk of cytomegalovirus infection after treatment of acute rejection in renal transplant recipientsMargaret R Jorgenson, Jillian L Descourouez, Beini Lyu, et al.
Clinical Nephrology|November 1, 2019
Alemtuzumab induction for retransplantation after primary transplant with alemtuzumab induction
Jillian L Descourouez, Margaret R Jorgenson, Sandesh Parajuli, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|October 4, 2020
Pre-transplant bariatric surgery is associated with increased fungal infection after liver transplantMargaret R Jorgenson, Adam S Gracon, Bret Hanlon, et al.
Virology : Research and Treatment|April 16, 2019
Very Early Cytomegalovirus Infection After Renal Transplantation: A Single-Center 20-Year PerspectiveM R Jorgenson, J L Descourouez, B C Astor, et al.
Pharmacotherapy|May 26, 2018
Impact of High-Dose Acyclovir Cytomegalovirus Prophylaxis Failure in Abdominal Solid Organ Transplant RecipientsMagdalena Siodlak, Margaret R Jorgenson, Jillian L Descourouez, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|November 20, 2021
Letermovir conversion after valganciclovir treatment in cytomegalovirus high-risk abdominal solid organ transplant recipients may promote development of cytomegalovirus-specific cell mediated immunityMargaret R Jorgenson, Hanna Kleiboeker, Neetika Garg, et al.
Clinical Transplantation|September 27, 2023
Real world experience with conversion from valganciclovir to letermovir for cytomegalovirus prophylaxis: Letermovir reverses leukopenia and avoids mycophenolate dose reductionMargaret R Jorgenson, Jillian L Descourouez, Christopher M Saddler, et al.
The Annals of Pharmacotherapy|August 29, 2017
High-Dose Acyclovir for Cytomegalovirus Prophylaxis in Seropositive Abdominal Transplant RecipientsMargaret R Jorgenson, Jillian L Descourouez, Glen E Leverson, et al.
Pageof 8

Showing results (31-40 of 72) with videos related to

Sort By:
Pageof 8
The Annals of Pharmacotherapy|May 18, 2017
Fosfomycin tromethamine for the Treatment of Cystitis in Abdominal Solid Organ Transplant Recipients With Renal DysfunctionLuiza Kerstenetzky, Margaret R Jorgenson, Jillian L Descourouez, et al.
Transplantation Direct|May 31, 2021
Geographic Distribution of Cytomegalovirus Serology in Kidney and Pancreas Transplant Recipients in the United StatesMargaret R Jorgenson, Sandesh Parajuli, Nicholas Marka, et al.
Clinical Transplantation|June 14, 2019
The risk of cytomegalovirus infection after treatment of acute rejection in renal transplant recipientsMargaret R Jorgenson, Jillian L Descourouez, Beini Lyu, et al.
Clinical Nephrology|November 1, 2019
Alemtuzumab induction for retransplantation after primary transplant with alemtuzumab induction
Jillian L Descourouez, Margaret R Jorgenson, Sandesh Parajuli, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|October 4, 2020
Pre-transplant bariatric surgery is associated with increased fungal infection after liver transplantMargaret R Jorgenson, Adam S Gracon, Bret Hanlon, et al.
Virology : Research and Treatment|April 16, 2019
Very Early Cytomegalovirus Infection After Renal Transplantation: A Single-Center 20-Year PerspectiveM R Jorgenson, J L Descourouez, B C Astor, et al.
Pharmacotherapy|May 26, 2018
Impact of High-Dose Acyclovir Cytomegalovirus Prophylaxis Failure in Abdominal Solid Organ Transplant RecipientsMagdalena Siodlak, Margaret R Jorgenson, Jillian L Descourouez, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|November 20, 2021
Letermovir conversion after valganciclovir treatment in cytomegalovirus high-risk abdominal solid organ transplant recipients may promote development of cytomegalovirus-specific cell mediated immunityMargaret R Jorgenson, Hanna Kleiboeker, Neetika Garg, et al.
Clinical Transplantation|September 27, 2023
Real world experience with conversion from valganciclovir to letermovir for cytomegalovirus prophylaxis: Letermovir reverses leukopenia and avoids mycophenolate dose reductionMargaret R Jorgenson, Jillian L Descourouez, Christopher M Saddler, et al.
The Annals of Pharmacotherapy|August 29, 2017
High-Dose Acyclovir for Cytomegalovirus Prophylaxis in Seropositive Abdominal Transplant RecipientsMargaret R Jorgenson, Jillian L Descourouez, Glen E Leverson, et al.
Pageof 8